# Evommune, Inc.: Form 8-K, filed Feb 10, 2026

- Company: [Evommune, Inc.](/companies/evmn.md) (CIK 2044725)
- Form: 8-K
- Filed: 2026-02-10
- Accepted by EDGAR: Feb 10, 2026, 08:28 ET
- Period: 2026-02-10
- Accession: 0001193125-26-043771
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2044725/000119312526043771/evmn-20260210.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2044725/000119312526043771/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2044725/000119312526043771/evmn-20260210.htm

Filed Feb 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-043771. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.